APA (7th ed.) Citation

YR, L., X, S., Y, C., Y, Z., J, H., C, O., & L, Y. (2026). Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia. Leukemia, 40(5), 880. https://doi.org/10.1038/s41375-026-02930-5

Chicago Style (17th ed.) Citation

YR, Li, Shen X, Chen Y, Zhu Y, Huang J, Oliai C, and Yang L. "Synergizing Hypomethylating Agents with Off-the-shelf CD70-targeted Chimeric Antigen Receptor-engineered Natural Killer T Cells for the Treatment of Acute Myeloid Leukemia." Leukemia 40, no. 5 (2026): 880. https://doi.org/10.1038/s41375-026-02930-5.

MLA (9th ed.) Citation

YR, Li, et al. "Synergizing Hypomethylating Agents with Off-the-shelf CD70-targeted Chimeric Antigen Receptor-engineered Natural Killer T Cells for the Treatment of Acute Myeloid Leukemia." Leukemia, vol. 40, no. 5, 2026, p. 880, https://doi.org/10.1038/s41375-026-02930-5.